首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer cell

缩写:CANCER CELL

ISSN:1535-6108

e-ISSN:1878-3686

IF/分区:56.1/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引3289
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Gal Yagel,Dana Rimini,Michelle von Locquenghien et al. Gal Yagel et al.
Chimeric antigen receptor (CAR) T cell therapy has shown remarkable success in hematologic malignancies and autoimmune diseases but remains limited in solid tumors due to antigen heterogeneity, escape, and an immunosuppressive tumor microen...
Boya Wang,George Wright,Julius C Enssle et al. Boya Wang et al.
Genetic and gene expression subtypes of diffuse large B cell lymphoma (DLBCL) have been defined using bulk tumor analysis. To explore their biology, we derived single-cell RNA and ATAC sequencing data from 103 DLBCL biopsies and identified ...
Jianan Li,Huilan Liu,Qile Guo et al. Jianan Li et al.
Clinical trials targeting cancer-associated fibroblasts (CAFs)-crucial pro-tumoral factors in cancer-have almost all failed. This may be ascribed to their intrinsic functional plasticity and the opaque regulatory circuits underlying their h...
Flavia Bernardi,Jacob Torrejon,Irene Basili et al. Flavia Bernardi et al.
Medulloblastoma, the most common malignant brain tumor of childhood, exhibits significant biological complexity that demands deeper exploration. Here, we present a large multiomics dataset integrating data from 384 primary medulloblastoma p...
Hyeji Jun,Yutaro Tanaka,Shreya Johri et al. Hyeji Jun et al.
The rapid expansion of molecularly informed therapies in oncology, coupled with evolving regulatory food and drug administration (FDA) approvals, poses a challenge for oncologists seeking to integrate precision oncology medicine into patien...
Valentin Marteau,Niloofar Nemati,Kristina Handler et al. Valentin Marteau et al.
The immune composition of the tumor microenvironment has a major impact on the therapy response in patients with colorectal cancer. Here, we built an atlas with 4.27 million single cells from 1,670 patient samples and complemented it with s...
Kenny Kwok Hei Yu,Zaki Abou-Mrad,Kristof Törkenczy et al. Kenny Kwok Hei Yu et al.
Primary de novo high grade gliomas, such as glioblastoma and lower grade gliomas both converge on a common aggressive phenotype, and the basis for this progression is unknown. Glioma associated macrophages (GAM) have been strongly implicate...
Andrea H Bild,Michelle C Sangar,Jasmine A McQuerry et al. Andrea H Bild et al.
ADAPT is a nationwide initiative to transform cancer care by detecting and responding to tumor evolution in real time. Integrating multimodal data, interpretable AI, and an evolutionary clinical trial platform, ADAPT predicts emerging resis...
Zile Fu,Yuanli Song,Fen Liu et al. Zile Fu et al.
Gallbladder cancer (GBC) is a highly aggressive malignancy with dismal outcomes. To dissect its molecular characteristics and identify potential therapeutic avenues, we performed proteogenomic characterization of 195 tumors and 135 adjacent...
Salvador Alonso,Kanwal Raghav,Van K Morris et al. Salvador Alonso et al.
Cancer evolution is a complex and dynamic process, yet most treatment strategies remain static. Infrequent tumor sampling has limited our ability to counteract the transient adaptive states that precede resistance. To address this gap, ARPA...